- Vaccine makers finally are studying the long-term consequences of vaccine-induced myocarditis and pericarditis – more than a year after the FDA added heart inflammation warnings to COVID-19 mRNA vaccines.
- Moderna already has two trials running, while Pfizer said its first trial will start “in the next couple months” and include up to 500 teenagers and young adults under 21.
- Meanwhile, the CDC is contacting people who meet the case definition of myocarditis and have been reported to the Vaccine Adverse Events Reporting System.
